C12N 2795/10121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2795/10121 (Viruses as such) appears on 70 US grants and 138 published applications in this corpus.
Search patents in C12N- Granted patents
- 70
- Published applications
- 138
- Assignees
- 73
- Inventors
- 282
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 0 |
| 2003 | 0 | 6 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 2 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 5 |
| 2016 | 2 | 4 |
| 2017 | 2 | 12 |
| 2018 | 4 | 5 |
| 2019 | 12 | 12 |
| 2020 | 4 | 11 |
| 2021 | 6 | 12 |
| 2022 | 4 | 18 |
| 2023 | 12 | 12 |
| 2024 | 4 | 15 |
| 2025 | 7 | 7 |
| 2026 | 6 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Therapeutic bacteriophages22 Sep 2026US 12,742,158 B2University of Leicester
- Methods and systems for the rapid detection of Listeria using infectious agents28 Jul 2026US 12,692,482 B2Laboratory Corporation of America Holdings
- Methods for purifying bacteriophage and products of manufacture containing endotoxin-free bacteriophage preparations9 Jun 2026US 12,648,976 B2San Diego State University (SDSU) Foundation
- Bacteriophage compositions for treating Pseudomonas infection7 Apr 2026US 12,594,312 B2Armata Pharmaceuticals, Inc.
- Peptide tags for phage imaging3 Sep 2026US 2026/0258373 A1The Regents of the University of California
- Bacteriophage(s) targeting capsular deficient klebsiella pneumoniae (kp), compositions comprising it(them) and use(s) thereof3 Sep 2026US 2026/0258374 A1
- Methods and compositions for conferring cellular resistance to viral infection3 Sep 2026US 2026/0258406 A1President and Fellows of Harvard College
- Systems and methods for generating bacteriophages adapted to infect a target bacterial strain20 Aug 2026US 2026/0242749 A1Baylor College of Medicine
- Listeria specific bacteriophage composition30 Jul 2026US 2026/0218134 A1Fundacion Azti-Azti Fundazioa
Most cited
By later US patents
- Bacteriophage composition useful in treating food products to prevent bacterial contamination21US 6,461,608 B1Nymox Pharmaceutical Corporation · 2002
- Bacteriophage RM 378 of a thermophilic host organism21US 6,492,161 B1Prokaria ltd. · 2002
- RNA ligase of bacteriophage RM 37821US 6,818,425 B2Prokaria ltd. · 2004
- Isolated phages and their use in food or pet food products12US 7,211,426 B2Nestec S. A. · 2007
- Methods and systems for rapid detection of microorganisms using infectious agents9US 10,519,483 B2Laboratory Corporation of America Holdings · 2019